Sprout CEO Cindy Eckert launched the world’s first drug approved to treat female sexual dysfunction and in 2015 sold it to Valeant for $1 billion. Three years …
source Bloomberg markets and Finace
How ‘female viagra’ could disrupt the $6bn sexual dysfunction industry
